Bringing doctors together

or

A free, private network for verified physicians

Leading voices

Dr. Hemant Murthy

BMT · Mayo Clinic Florida

View

Dr. Talal Hilal

Lymphoma · Mayo Clinic College of Medicine

View

Dr. Midhun Malla

GI Oncology · UAB

View

Dr. Saad Usmani

Myeloma · MSK

View

Dr. Kamal Menghrajani

Leukemia · MGH

View

Dr. Hope Rugo

Breast Oncology · City of Hope

View

Dr. Gideon Dosunmu

GI Oncology · Emory Hospital Midtown

View

Dr. Pavlos Msaouel

GU Oncology · MD Anderson Cancer Center

View

Dr. Virginia Borges

Breast Oncology · CU Anschutz Medical Campus

View

Dr. Naval Daver

Leukemia · MD Anderson Cancer Center

View
  • Discover your community

  • Stay current

  • A profile that represents you

  • Find your people

About RoonPrivacyTerms
    ASDr. Anurag Singh

    Dr. Anurag Singh

    Hematology & Oncology · Bone Marrow Transplant (BMT)
    University of Kansas Medical Center
    anurag

    Research

    Impact of transplant conditioning, NPM1 mutations, and measurable residual disease in FLT3-ITD acute myeloid leukemia

    2025

    Via Blood Advances

    Research

    Measurable residual disease and posttransplantation gilteritinib maintenance for patients with FLT3-ITD-mutated AML

    2025

    Via Blood

    Research

    Concurrent intravenous immunoglobulin and platelet transfusion for refractory alloimmune thrombocytopenia in patients undergoing allogeneic hematopoietic stem cell transplantation

    2025

    Via Hematology, Transfusion and Cell Therapy

    Research

    Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation in Older Patients Aged 65 Years and Above With Myelofibrosis

    2025

    Via Clinical Lymphoma, Myeloma & Leukemia

    Research

    Gilteritinib as Post-Transplant Maintenance for AML With Internal Tandem Duplication Mutation of FLT3

    2024

    Via Journal of Clinical Oncology

    Research

    Efficacy of Ruxolitinib with corticosteroids in idiopathic pneumonia syndrome post-allogeneic hematopoietic stem cell transplantation: A single-center experience and systematic review

    2024

    Via Transplant Immunology

    Research

    Use of Endpoints in Phase III Randomized Controlled Trials for Hematopoietic Stem Cell Transplantation Over the Last 15 Years: A Systematic Review

    2024

    Via Hematology/Oncology and Stem Cell Therapy

    Research

    Predictors of cytomegalovirus reactivation after allogeneic hematopoietic cell transplantation: Insights from a real-world experience

    2024

    Via Transplant Immunology

    Research

    Outcomes with HLA-matched unrelated donor versus haploidentical hematopoietic cell transplantation

    2024

    Via Leukemia & Lymphoma

    Research

    Comparison of biosimilar filgrastim and originator filgrastim for peripheral blood stem cell mobilization for allogeneic hematopoietic stem cell transplantation

    2024

    Via Transfusion

    Research

    Outcomes with allogeneic hematopoietic stem cell transplantation in TP53-mutated myelodysplastic syndrome: A systematic review and meta-analysis

    2024

    Via Critical Reviews in Oncology/Hematology

    Research

    Favorable outcomes following CD34-selected stem cell boost for poor graft function after allogeneic hematopoietic stem cell transplantation

    2023

    Via Bone Marrow Transplantation

    Research

    Lessons learned from COVID-19 pandemic: outcomes after SARS-CoV-2 infection in hematopoietic cell transplant and cell therapy recipients

    2023

    Via Leukemia & Lymphoma

    Research

    Impact of natural killer cells on outcomes after allogeneic hematopoietic stem cell transplantation: A systematic review and meta-analysis

    2022

    Via Frontiers in Immunology

    Research

    Outcomes with allogeneic hematopoietic stem cell transplantation in TP53-mutated acute myeloid leukemia: a systematic review and meta-analysis

    2022

    Via Leukemia & Lymphoma